logo
Plus   Neg
Share
Email

Alexion Boosts FY19 Outlook - Quick Facts

While reporting financial results for the second quarter, Alexion Pharmaceuticals, Inc. (ALXN) on Wednesday raised its adjusted earnings and revenue guidance for the full year 2019 to reflect strength of the business and continued growth.

For fiscal 2019, the company now projects earnings in a range of $8.13 to $8.41 per share and adjusted earnings in a range of $9.65 to $9.85 per share on total revenues between $4.75 billion and $4.80 billion.

Previously, the company projected earnings in a range of $6.76 to $7.96 per share and adjusted earnings in a range of $9.25 to $9.45 per share on total revenues between $4.675 billion and $4.75 billion.

On average, analysts polled by Thomson Reuters expect earnings of $9.44 per share on revenues of $4.78 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The National Retail Federation or NRF said that conflicting economic data amid a resurgence in coronavirus cases has made it difficult to predict how steadily the U.S. economic recovery will continue. NRF Chief Economist Jack Kleinhenz noted that based on quarterly and monthly data, the U.S. economic recovery is continuing despite the elevated COVID-19 cases. Ford Motor Company (F) announced that Jim Hackett plans to retire as President and CEO. He will continue as a special advisor to the company through March of 2021. The company has named Jim Farley as new president and CEO. He will join the board of directors, effective Oct. 1. Farley joined Ford in... Google parent Alphabet Inc. has issued $5.75 billion in sustainability bonds, becoming the largest green or sustainability bonds issued by a company until now. This is part of a $10 billion debt offering. Alphabet said the proceeds will be used to fund projects that are environmentally or socially responsible.
Follow RTT